Authors


Chevannah Hardie, PharmD Candidate

Latest:

Acne Can Be Troublesome But Responds to Treatment

For best results, address this common, chronic, inflammatory skin condition’s pathogenesis, and consider the possibility of resistance and recurrence.


Dragos Plesca, PharmD, PhD

Latest:

Melanoma: Therapy Update

The approval of ipilimumab and vemurafenib in 2011 marked a significant advance in the treatment of melanoma, and a number of new investigational agents are in the pipeline.


Andrew L. Wilson, PharmD, FASHP, Vice President, McKesson 340B Solutions

Latest:

Understanding and Navigating Specialty and Orphan Drug Challenges in the 340B Program

Failure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.


Lindsey Butler, PharmD, AAHVIP

Latest:

PCSK9 Inhibitors: Who are the Best Candidates for Therapy?

Varying strategies among managed care organizations for PCSK9 inhibitors will shape the care of high-risk cardiovascular patients.


Christopher Ogurchak, PharmD, MSPBA

Latest:

We Don't Need No Education: Post-Pharmacy School Options

Upon successfully earning an RPh or PharmD degree, many newly minted pharmacists likely exhale deeply, with the belief that the education requirements for a successful career have finally been satisfied.


Rajesh Nair PhD, Rph

Latest:

Reducing 30-day Readmission Rates Through Compliance Calls Post-Discharge

The discharge pharmacy service at West Virginia University (WVU) Medicine in Morgantown is intended to be a ‘patient first’ program that ensures patients receive the medications prescribed in hand, and that they remain adherent through medication counseling and followup.


Nikhil Patel, PharmD, RPh

Latest:

Zinc and Zinc Preparations for Colds: An Update for Pharmacists

Pharmacists can learn about the impact of the common cold on adults and children and describe the potential role of zinc-based options for patients.



Curtis E. Haas, PharmD, FCCP, Pharmacy Times Directions in Health-System Pharmacy Editor-in-Chief

Latest:

Patient Assistance Programs: The Good, the Bad, and the Ugly

For many years, employers, payers, and pharmacy benefit managers have been developing benefit designs to incentivize patients and providers to make cost-effective treatment decisions.


Ashley Saclolo, MS, PharmD Candidate

Latest:

Motivational Interviewing: Effective Communication is Important for Technicians

Effective communication is among the most important skills for pharmacy technicians, yet one that is often overlooked.




Osama Abdelghany, PharmD, MHA, BCOP

Latest:

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center

At the Smilow Cancer Hospital, oncology pharmacists play an important role in the delivery of care for patients with cancer.


Jianwei Leng, MS

Latest:

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.


Michelle Luo, PhD

Latest:

Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and Costs

Real-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.


Mary-Haston Leary, PharmD, MS, BCPS

Latest:

Data Aggregation in Specialty Pharmacy

The value of big data in health care is realized when raw data are transformed into insights that drive practice change and decision making.




Srihari Jaganathan, MS

Latest:

Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease

This study evaluated the rates of dose escalation in patients with Crohn's disease.





Evidence-Based Diabetes Management

Latest:

The Formularies Fight Back: AJMC Panelists Discuss How Discounts, Exclusivity Deals Should Expand HCV Treatment

Panelists agreed that the trend of specialization of traditional drug classes has implications not only for costs, but also for the role of community pharmacy if more drugs fall into the specialty pharmacy realm.


Pamela Koerner, PharmD

Latest:

Rare Pharmacy Emerges From Specialty: Part 1

The rarity of disease states coupled with novel medication mechanisms and high costs lead to complexities in accessing treatment and optimizing outcomes.


Jennifer White, PharmD

Latest:

Proper Sun Safety is Important Year-Round: Counseling Points for Pharmacists

Despite it being fall, sun safety is important all year and even needs to be considered for winter sport activities, such as snowboarding and skiing.


John D. Musil, PharmD, FACA

Latest:

The Apothecary Shops Becomes Avella Specialty Pharmacy

The Apothecary Shops has grown over the past 16 years and evolved from a single compounding pharmacy to one of the most trusted specialty pharmacies in the nation. The company reveals its new name and it's continued commitment to health and devotion to excellence.


Brandon Tom, PharmD

Latest:

How Specialty Pharmacies Can Improve Transitional Care Amid COVID-19

As clinicians, we must first understand the unique challenges that a patient is facing and then tailor our support to address their specific needs.


Michael Bartholow, PharmD, CACP

Latest:

Top Drugs of 2015

Medication spending grew by 12.2% in 2015, totaling approximately $425 billion.


Joe DePinto

Latest:

Cell and Gene Therapies: Overcoming Barriers to Realize Transformative Potential

Clinicians' enthusiasm for cell and gene therapies is tempered by practical concerns.